Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/88605
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans
Author: Wilson, D.
Fowkes, F.
Gilson, P.
Elliott, S.
Tavul, L.
Michon, P.
Dabod, E.
Siba, P.
Mueller, I.
Crabb, B.
Beeson, J.
Citation: PLoS One, 2011; 6(11):e27705-1-e27705-14
Publisher: Public Library of Science
Issue Date: 2011
ISSN: 1932-6203
1932-6203
Statement of
Responsibility: 
Danny W. Wilson, Freya J. I. Fowkes, Paul R. Gilson, Salenna R. Elliott, Livingstone Tavul, Pascal Michon, Elija Dabod, Peter M. Siba, Ivo Mueller, Brendan S. Crabb, James G. Beeson
Abstract: Background: Antibodies targeting blood stage antigens are important in protection against malaria, but the key targets and mechanisms of immunity are not well understood. Merozoite surface protein 1 (MSP1) is an abundant and essential protein. The C-terminal 19 kDa region (MSP1-19) is regarded as a promising vaccine candidate and may also be an important target of immunity. Methodology/Findings: Growth inhibitory antibodies against asexual-stage parasites and IgG to recombinant MSP1-19 were measured in plasma samples from a longitudinal cohort of 206 children in Papua New Guinea. Differential inhibition by samples of mutant P. falciparum lines that expressed either the P. falciparum or P. chabaudi form of MSP1-19 were used to quantify MSP1-19 specific growth-inhibitory antibodies. The great majority of children had detectable IgG to MSP1-19, and high levels of IgG were significantly associated with a reduced risk of symptomatic P. falciparum malaria during the 6-month follow-up period. However, there was little evidence of PfMSP1-19 specific growth inhibition by plasma samples from children. Similar results were found when testing non-dialysed or dialysed plasma, or purified antibodies, or when measuring growth inhibition in flow cytometry or microscopy-based assays. Rabbit antisera generated by immunization with recombinant MSP1-19 demonstrated strong MSP1-19 specific growth-inhibitory activity, which appeared to be due to much higher antibody levels than human samples; antibody avidity was similar between rabbit antisera and human plasma. Conclusions/Significance: These data suggest that MSP1-19 is not a major target of growth inhibitory antibodies and that the protective effects of antibodies to MSP1-19 are not due to growth inhibitory activity, but may instead be mediated by other mechanisms. Alternatively, antibodies to MSP1-19 may act as a marker of protective immunity.
Keywords: Animals; Humans; Plasmodium falciparum; Parasitemia; Malaria; Recurrence; Merozoite Surface Protein 1; Antibodies, Protozoan; Vaccination; Antibody Specificity; Molecular Weight; Adolescent; Child; Child, Preschool; Adaptive Immunity
Rights: © 2011 Wilson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
RMID: 0020138004
DOI: 10.1371/journal.pone.0027705
Appears in Collections:Microbiology and Immunology publications

Files in This Item:
File Description SizeFormat 
hdl_88605.pdfPublished version840.22 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.